Temporal trends in the prescription of vitamin K antagonists in patients with atrial fibrillation
| Autor: | Søren K. Rasmussen, N. Gadsboell, Torp-Pedersen Ct, Jeppe Nørgaard Rasmussen, Lars Køber, Steen Zabell Abildstrøm, Jens Friberg, Gunnar Gislason, Mette Madsen |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
Male
medicine.medical_specialty Pediatrics Vitamin K Heart disease medicine.drug_class Denmark Physician's Practice Patterns Danish Sex Factors Atrial Fibrillation Epidemiology Internal Medicine Humans Medicine Registries Practice Patterns Physicians' Medical prescription Stroke Aged Aged 80 and over business.industry Public health Anticoagulant Anticoagulants Atrial fibrillation Middle Aged medicine.disease language.human_language Hospitalization Logistic Models language Female business |
| Zdroj: | Friberg, J, Gislason, G H, Gadsbøll, N, Rasmussen, J N, Rasmussen, S, Abildstrøm, S Z, Køber, L, Madsen, M & Torp-Pedersen, C 2006, ' Temporal trends in the prescription of vitamin K antagonists in patients with atrial fibrillation ', Journal of Internal Medicine, vol. 259, no. 2, pp. 173-8 . https://doi.org/10.1111/j.1365-2796.2005.01595.x |
| ISSN: | 1365-2796 0954-6820 |
| DOI: | 10.1111/j.1365-2796.2005.01595.x |
| Popis: | Friberg J, Gislason GH, Gadsboll N,Rasmussen JN, Rasmussen S, Abildstrom SZ, KoberL, Madsen M, Torp-Pedersen C (Hvidovre UniversityHospital, Copenhagen; Bispebjerg UniversityHospital, Copenhagen; National Institute of PublicHealth, Copenhagen; Gentofte University Hospital,Gentofte; and National University Hospital,Copenhagen; Denmark). Temporal trends in theprescription of vitamin K antagonists in patientswith atrial fibrillation. J Intern Med 2006; 259: 173–178.Objectives. Anticoagulation therapy isrecommended in patients with atrial fibrillation(AF) and risk factors for stroke. We studied thetemporal trends in the prescription of vitamin Kantagonists (VKA) in patients with a first hospitaldiagnosis of AF in Denmark, 1995–2002.Design. The Danish National Hospital Registry wasused to identify subjects with a first hospitaldiagnosis of AF and the Danish Register of MedicalProducts Statistics to determine the proportion ofthese patients who claimed a prescription of VKAwithin 3 months from discharge.Results. Amongst 68 546 patients aged 50–99 years with a diagnosis of AF who survived3 months following discharge, 24 991 (36%)patients claimed a prescription of VKA within3 months. In both men and women a gradualincrease in the use of VKA with time was observed,the relative increase being largest amongst the 80-to 99-year olds. In all age groups, the prescription ofVKA was lower in women than in men, includingpatients with a prior or concurrent stroke.Conclusions. From 1995 to 2002 the proportion ofAF patients receiving VKA therapy increasedsignificantly but the use of VKA therapy amongstwomen was lagging behind that of men. Even inpatients with AF and prior stroke, the use of VKAseems to be less than optimal.Keywords: anticoagulants, atrial fibrillation,epidemiology, stroke. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text